Results
233
Companies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.
233 companies
Travere Therapeutics
Market Cap: US$1.8b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$20.23
7D
-2.8%
1Y
196.6%
Alnylam Pharmaceuticals
Market Cap: US$35.2b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$276.55
7D
5.1%
1Y
81.6%
Ascendis Pharma
Market Cap: US$9.8b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$160.99
7D
-5.5%
1Y
20.2%
AVITA Medical
Market Cap: US$243.5m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$9.47
7D
-2.3%
1Y
5.6%
Alkami Technology
Market Cap: US$2.8b
Provides cloud-based digital banking solutions in the United States.
ALKT
US$28.00
7D
4.9%
1Y
5.4%
Lumentum Holdings
Market Cap: US$4.5b
Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
LITE
US$66.24
7D
12.2%
1Y
55.5%
TG Therapeutics
Market Cap: US$5.5b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$34.85
7D
-23.4%
1Y
103.6%
Ardelyx
Market Cap: US$945.1m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.70
7D
-32.8%
1Y
-56.4%
Super Micro Computer
Market Cap: US$19.7b
Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.
SMCI
US$32.48
7D
1.9%
1Y
-60.5%
Clene
Market Cap: US$24.6m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$2.55
7D
-14.1%
1Y
-67.3%
Bitdeer Technologies Group
Market Cap: US$2.1b
Operates as a technology company for blockchain and computing.
BTDR
US$11.35
7D
18.6%
1Y
101.1%
CoreWeave
Market Cap: US$25.2b
Operates a cloud platform that provides scaling, support, and acceleration for GenAI.
CRWV
US$53.60
7D
29.8%
1Y
n/a
Blueprint Medicines
Market Cap: US$6.4b
A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.
BPMC
US$99.80
7D
11.5%
1Y
-8.3%
Core Scientific
Market Cap: US$2.7b
Provides digital asset mining services in the United States.
CORZ
US$8.90
7D
9.9%
1Y
155.7%
Applied Optoelectronics
Market Cap: US$773.9m
Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.
AAOI
US$13.98
7D
9.3%
1Y
29.1%
Red Cat Holdings
Market Cap: US$481.5m
Provides products and solutions to drone industry in the United States.
RCAT
US$5.38
7D
7.2%
1Y
352.1%
Alvotech
Market Cap: US$2.4b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$7.94
7D
1.3%
1Y
-41.4%
Palantir Technologies
Market Cap: US$256.9b
Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.
PLTR
US$110.48
7D
-6.7%
1Y
412.4%
Legend Biotech
Market Cap: US$5.8b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$31.47
7D
-10.0%
1Y
-31.2%
Duos Technologies Group
Market Cap: US$75.7m
Designs, develops, deploys, and operates intelligent technology solutions in North America.
DUOT
US$6.58
7D
-13.8%
1Y
114.3%
UroGen Pharma
Market Cap: US$446.7m
Engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$10.12
7D
-13.1%
1Y
-23.7%
Abeona Therapeutics
Market Cap: US$279.3m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$5.27
7D
-19.7%
1Y
19.7%
TruGolf Holdings
Market Cap: US$11.5m
Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.
TRUG
US$0.27
7D
-3.1%
1Y
-83.1%
MeiraGTx Holdings
Market Cap: US$462.9m
A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.
MGTX
US$5.41
7D
-23.7%
1Y
5.3%
Vanda Pharmaceuticals
Market Cap: US$257.5m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.38
7D
-2.9%
1Y
-18.3%
TeraWulf
Market Cap: US$1.2b
Operates as a digital asset technology company in the United States.
WULF
US$3.05
7D
9.7%
1Y
30.9%
Nutanix
Market Cap: US$19.3b
Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.
NTNX
US$73.70
7D
7.3%
1Y
11.3%
Workday
Market Cap: US$66.3b
Provides enterprise cloud applications in the United States and internationally.
WDAY
US$250.58
7D
2.3%
1Y
0.4%
OS Therapies
Market Cap: US$50.7m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.84
7D
-9.4%
1Y
n/a
Gorilla Technology Group
Market Cap: US$282.0m
Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in the Asia Pacific region, the Americas, Cayman Islands, and internationally.
GRRR
US$14.85
7D
-23.7%
1Y
162.8%
Sarepta Therapeutics
Market Cap: US$4.6b
A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
SRPT
US$36.72
7D
-41.2%
1Y
-72.3%
Capricor Therapeutics
Market Cap: US$333.4m
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$6.89
7D
-45.7%
1Y
28.3%
Exelixis
Market Cap: US$10.2b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$36.81
7D
-6.0%
1Y
70.5%
Smith Micro Software
Market Cap: US$16.4m
Develops and sells software solutions to simplify and enhance the mobile experience to wireless and cable service providers in the Americas, Europe, the Middle East, and Africa.
SMSI
US$1.05
7D
5.6%
1Y
-57.3%
Spotify Technology
Market Cap: US$129.8b
Provides audio streaming subscription services worldwide.
SPOT
US$657.10
7D
7.0%
1Y
120.0%
Zscaler
Market Cap: US$36.1b
Operates as a cloud security company worldwide.
ZS
US$233.54
7D
3.3%
1Y
36.6%